The fight against counterfeit medicines
25 April 2016 | By Victoria White, Digital Content Producer
New research is providing the foundation to apply criminology theory to preventing the production and sale of counterfeit medicines...
List view / Grid view
News
Trial supports safety and efficacy profile of Pfizer’s varenicline
22 April 2016 | By Victoria White, Digital Content Producer
EAGLES compared the neuropsychiatric safety and efficacy of varenicline and bupropion to placebo and nicotine patch to help people quit smoking...
TPIV 200 and durvalumab to be evaluated in a Phase II ovarian cancer study
22 April 2016 | By Victoria White, Digital Content Producer
TapImmune plans to initiate a Phase II trial of TPIV 200 in combination with AstraZeneca’s durvalumab in patients with platinum-resistant ovarian cancer...
Daclizumab demonstrates significant improvements in cognition in RRMS
22 April 2016 | By Victoria White, Digital Content Producer
New data demonstrates daclizumab’s positive cognitive outcomes and safety profile in patients with relapsing-remitting multiple sclerosis (RRMS)...
Allergan acquires topical dermatology company Topokine Therapeutics
22 April 2016 | By Victoria White, Digital Content Producer
Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5...
NICE U-turn on cabazitaxel for prostate cancer
22 April 2016 | By Victoria White, Digital Content Producer
NICE has issued final guidance recommending Sanofi’s Jevtana (cabazitaxel) for some prostate cancer patients...
Amgen’s Nplate shows significant increase in durable platelet response in ITP
21 April 2016 | By Victoria White, Digital Content Producer
A Phase III study shows that 52 percent of Nplate patients achieved a durable platelet response, compared with 10 percent of placebo-treated patients...
BIA leads international call to review US court decision
21 April 2016 | By The UK BioIndustry Association (BIA)
The UK BioIndustry Association has urged the US Supreme Court to review a decision of a lower court that could hinder the development of new diagnostics and medicines...
RedHill Biopharma announces positive FDA meeting on RHB-105
21 April 2016 | By Victoria White, Digital Content Producer
RedHill Biopharma has concluded a positive Type B Meeting with the FDA regarding the path to marketing approval of RHB-105...
Novo Nordisk to invest EUR 100 million in production facilities
21 April 2016 | By Victoria White, Digital Content Producer
Novo Nordisk has announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France...
Afinitor significantly reduces seizures in Phase III TSC study
21 April 2016 | By Victoria White, Digital Content Producer
Results from a Phase III study show Novartis’ Afinitor (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures...
Positive top-line results from the Phase III PALOMA-2 trial
20 April 2016 | By Victoria White, Digital Content Producer
Pfizer has announced positive top-line results from the Phase III PALOMA-2 trial for Ibrance (palbociclib) in breast cancer...
CPhI Istanbul hosts government and industry to strengthen Turkey’s role as MENA’s pharma hub
20 April 2016 | By CPhI
CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC...
Positive Phase I results for preventive Ebola vaccine regimen
20 April 2016 | By Victoria White, Digital Content Producer
Data from a Phase I study of a preventive Ebola vaccine regimen suggest that the regimen was well-tolerated by healthy volunteers and immunogenic...
Immuno-oncology market to hit $34 billion by 2024, says GlobalData
19 April 2016 | By Victoria White, Digital Content Producer
The total immuno-oncology market will be worth approximately $14 billion by 2019, rising to $34 billion by 2024, according to GlobalData...
